Loading clinical trials...
Loading clinical trials...
Pilot Study of First-line Immunosuppressive Therapy Combined With Etoposide and Allogeneic Hematopoietic Cell Transplantation in Refractory/Reactivated Cases for Hemophagocytic Lymphohistiocytosis (HLH) in Adult Patients
Conditions
Interventions
IST and/or alloHCT
Locations
1
South Korea
Asan Medical center, University of Ulsan College of Medicine
Seoul, South Korea
Start Date
March 1, 2012
Primary Completion Date
May 1, 2016
Completion Date
May 1, 2016
Last Updated
July 20, 2018
NCT03259230
NCT05841342
NCT01998633
NCT05384743
NCT04077905
NCT01818908
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions